Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol

J Am Coll Cardiol. 2018 Feb 13;71(6):633-635. doi: 10.1016/j.jacc.2017.12.040.

Authors

Manuel Mayr¹, Robert Gerszten², Stefan Kiechl³

Affiliations

¹ King's British Heart Foundation Centre, King's College London, London, United Kingdom. Electronic address: manuel.mayr@kcl.ac.uk.
² Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
³ Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

PMID: 29420959
DOI: 10.1016/j.jacc.2017.12.040

No abstract available

Keywords: apolipoproteins; biomarkers; mass spectrometry; nuclear magnetic resonance spectroscopy; precision medicine.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiovascular Diseases*
Cholesterol, HDL
Cholesterol, LDL
Humans
Lipids
Lipoproteins
Myocardial Infarction*
Risk Factors
Stroke*

Substances

Cholesterol, HDL
Cholesterol, LDL
Lipids
Lipoproteins

Grants and funding